{"id":25395,"date":"2026-02-16T16:31:23","date_gmt":"2026-02-16T15:31:23","guid":{"rendered":"https:\/\/www.franceangels.org\/?p=25395"},"modified":"2026-02-23T10:04:31","modified_gmt":"2026-02-23T09:04:31","slug":"angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/","title":{"rendered":"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics"},"content":{"rendered":"\n<p><strong><a href=\"https:\/\/apmonia-therapeutics.com\" target=\"_blank\" rel=\"noreferrer noopener\">Apmonia Therapeutics<\/a><\/strong> franchit une \u00e9tape cl\u00e9 de son d\u00e9veloppement avec une&nbsp;<strong>lev\u00e9e de fonds de 10 millions d\u2019euros<\/strong>, destin\u00e9e \u00e0 accompagner l\u2019entr\u00e9e de son candidat phare&nbsp;<strong>TAX2&nbsp;<\/strong>en<strong>&nbsp;premi\u00e8re administration chez l\u2019humain.<\/strong><\/p>\n\n\n\n<p>Fond\u00e9e par&nbsp;<strong><a href=\"https:\/\/www.linkedin.com\/in\/albin-jeanne-49269778\/\" target=\"_blank\" rel=\"noreferrer noopener\">Albin Jeanne<\/a><\/strong>, Apmonia Therapeutics est une soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e dans le d\u00e9veloppement d\u2019<strong>immunoth\u00e9rapies innovantes contre le cancer,<\/strong>&nbsp;ciblant le&nbsp;<strong>microenvironnement tumoral<\/strong>. Son peptide TAX2 vise sp\u00e9cifiquement les tumeurs surexprimant la <strong>thrombospondine-1 (TSP-1).<\/strong><\/p>\n\n\n\n<p>En parall\u00e8le, l\u2019entreprise s\u2019appuie sur une&nbsp;<strong>plateforme de d\u00e9couverte exclusive d\u00e9di\u00e9e \u00e0 la matrice extracellulaire (MEC).<\/strong>&nbsp;Cette plateforme combine&nbsp;<strong>mod\u00e9lisation mol\u00e9culaire avanc\u00e9e,&nbsp;conception de peptides assist\u00e9e par l\u2019intelligence artificielle<\/strong>&nbsp;et <strong>une expertise approfondie en biologie de la MEC<\/strong>, afin de g\u00e9n\u00e9rer d\u2019autres candidats m\u00e9dicaments capables de perturber les interactions tumeur-stroma et de surmonter la r\u00e9sistance th\u00e9rapeutique.<\/p>\n\n\n\n<p>Ce financement r\u00e9unit les&nbsp;<strong>investisseurs historiques<\/strong>&nbsp;d\u2019Apmonia Therapeutics&nbsp;: <strong><a href=\"http:\/\/www.capitalgrandest.eu\" target=\"_blank\" rel=\"noreferrer noopener\">Capital Grand-Est<\/a><\/strong>, <strong><a href=\"https:\/\/finovamgestion.fr\" target=\"_blank\" rel=\"noreferrer noopener\">FINOVAM Gestion<\/a><\/strong>, la <strong><a href=\"http:\/\/www.fournier-majoie.org\/fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">fondation Fournier-Majoie<\/a><\/strong> et <strong><a href=\"https:\/\/www.angelssante.fr\" target=\"_blank\" rel=\"noreferrer noopener\">Angels Sant\u00e9<\/a><\/strong> aux c\u00f4t\u00e9s de&nbsp;<strong>nouveaux investisseurs priv\u00e9s<\/strong>&nbsp;et de<strong>&nbsp;<a href=\"https:\/\/capitalcell.com\/fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Capital Cell<\/a>.<\/strong><\/p>\n\n\n\n<p>Les fonds lev\u00e9s permettront de :<\/p>\n\n\n\n<ul><li><strong>Lancer une \u00e9tude clinique de phase 1\/2a<\/strong>\u00a0<strong>du TAX2<\/strong> chez des patients atteints de\u00a0tumeurs solides avanc\u00e9es<strong>,<\/strong>\u00a0en France et en Belgique.<\/li><li><strong>Poursuivre<\/strong>\u00a0<strong>le d\u00e9veloppement de la plateforme propri\u00e9taire MEC\u00a0<\/strong>afin de g\u00e9n\u00e9rer de nouveaux actifs th\u00e9rapeutiques \u00e0 base de peptides.<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Apmonia Therapeutics franchit une \u00e9tape cl\u00e9 de son d\u00e9veloppement avec une&nbsp;lev\u00e9e de fonds de 10 millions d\u2019euros, destin\u00e9e \u00e0 accompagner l\u2019entr\u00e9e de son candidat phare&nbsp;TAX2&nbsp;en&nbsp;premi\u00e8re administration chez l\u2019humain. Fond\u00e9e par&nbsp;Albin Jeanne, Apmonia Therapeutics est une soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e dans le d\u00e9veloppement d\u2019immunoth\u00e9rapies innovantes contre le cancer,&nbsp;ciblant le&nbsp;microenvironnement tumoral. Son peptide TAX2 vise sp\u00e9cifiquement les&hellip;<\/p>\n","protected":false},"author":114,"featured_media":25396,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[1711,85],"tags":[147,786,1665,1663,181,1749,1750,78,75,76],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.7.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics - France Angels\" \/>\n<meta property=\"og:description\" content=\"Apmonia Therapeutics franchit une \u00e9tape cl\u00e9 de son d\u00e9veloppement avec une&nbsp;lev\u00e9e de fonds de 10 millions d\u2019euros, destin\u00e9e \u00e0 accompagner l\u2019entr\u00e9e de son candidat phare&nbsp;TAX2&nbsp;en&nbsp;premi\u00e8re administration chez l\u2019humain. Fond\u00e9e par&nbsp;Albin Jeanne, Apmonia Therapeutics est une soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e dans le d\u00e9veloppement d\u2019immunoth\u00e9rapies innovantes contre le cancer,&nbsp;ciblant le&nbsp;microenvironnement tumoral. Son peptide TAX2 vise sp\u00e9cifiquement les&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-16T15:31:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T09:04:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2026\/02\/6.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1633\" \/>\n\t<meta property=\"og:image:height\" content=\"805\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics\",\"datePublished\":\"2026-02-16T15:31:23+00:00\",\"dateModified\":\"2026-02-23T09:04:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/\"},\"wordCount\":264,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Angels Sant\u00e9\",\"Apmonia Therapeutics\",\"Capital Cell\",\"Capital Grand Est\",\"Closing\",\"FINOVAM GEstion\",\"fondation Fournier Majoie\",\"France Angels\",\"Lev\u00e9e de fonds\",\"R\u00e9seaux de Business Angels\"],\"articleSection\":[\"2026\",\"Closing\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/\",\"name\":\"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2026-02-16T15:31:23+00:00\",\"dateModified\":\"2026-02-23T09:04:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics - France Angels","og_description":"Apmonia Therapeutics franchit une \u00e9tape cl\u00e9 de son d\u00e9veloppement avec une&nbsp;lev\u00e9e de fonds de 10 millions d\u2019euros, destin\u00e9e \u00e0 accompagner l\u2019entr\u00e9e de son candidat phare&nbsp;TAX2&nbsp;en&nbsp;premi\u00e8re administration chez l\u2019humain. Fond\u00e9e par&nbsp;Albin Jeanne, Apmonia Therapeutics est une soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e dans le d\u00e9veloppement d\u2019immunoth\u00e9rapies innovantes contre le cancer,&nbsp;ciblant le&nbsp;microenvironnement tumoral. Son peptide TAX2 vise sp\u00e9cifiquement les&hellip;","og_url":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2026-02-16T15:31:23+00:00","article_modified_time":"2026-02-23T09:04:31+00:00","og_image":[{"width":1633,"height":805,"url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2026\/02\/6.png","type":"image\/png"}],"author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics","datePublished":"2026-02-16T15:31:23+00:00","dateModified":"2026-02-23T09:04:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/"},"wordCount":264,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Angels Sant\u00e9","Apmonia Therapeutics","Capital Cell","Capital Grand Est","Closing","FINOVAM GEstion","fondation Fournier Majoie","France Angels","Lev\u00e9e de fonds","R\u00e9seaux de Business Angels"],"articleSection":["2026","Closing"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/","url":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/","name":"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2026-02-16T15:31:23+00:00","dateModified":"2026-02-23T09:04:31+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/angels-sante-renouvelle-sa-confiance-dans-apmonia-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Angels Sant\u00e9 renouvelle sa confiance dans Apmonia Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/25395"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=25395"}],"version-history":[{"count":2,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/25395\/revisions"}],"predecessor-version":[{"id":25482,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/25395\/revisions\/25482"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media\/25396"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=25395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=25395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=25395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}